JohnMSloanMD

PubMed

• 88 citations
  Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience.
  Vaishali Sanchorawala, Fangui Sun, Karen Quillen, J. Mark Sloan, John L. Berk
  Blood. 2015-11-12
• 15 citations
  Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis
  Shayna Sarosiek, Luke Zheng, J. Mark Sloan, Karen Quillen, Dina Brauneis
  Blood Cancer Journal. 2020-09-01
• 4 citations
  Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes.
  Joshua N Gustine, Raphael E Szalat, Andrew Staron, Tracy Joshi, Lisa Mendelson
  Haematologica. 2023-06-01

Journal Articles

• Heparin-Induced Thrombocytopenia and Thrombosis During High Dose Melphalan and Autologous Stem Cell Transplantation  
  Dina Brauneis, Vaishali Sanchorawala, J Mark Sloan, Shayna Sarosiek, Blood
• Beyond Methotrexate: Treatment of Residual Disease in Primary Central Nervous System Lymphoma  
  Sloan JM, Hochberg E, Hochberg F, The American Journal of Hematology/Oncology, 1/1/2007
• Contrast mechanisms for scanning tunneling microscopy of biological molecules  
  Sloan JM and Smith WF, Probe Microscopy, 1/1/1997
• Simple retrofittable long-range x-y translation system for scanned probe microscopes  
  Smith WF, Abraham MC, Sloan JM, Switkes M, Review of Scientific Instruments, 1/1/1996
• Join now to see all

Books/Book Chapters

• ACP Medicine 
  Chapter: Approach to the patient with benign hematologic disorders. 
  Sloan JM, Seldin DC2013
• Multiple Myeloma: Pursuing the Plasma Cell 
  Chapter: Anemia and Erythropoeitic Growth factors in Multiple Myeloma. 
  Sloan JM, Raje NEditors: Sagar Lonial.Humana Press2008

Abstracts/Posters

• The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease
  John Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Patients with Sickle Cell Disease and Venous Thromboembolism Experience Increased Frequency of Vasoocclusive Events
  John Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Successful Transition from Bortezomib Subcutaneous (SubQ) to Generic Intravenous (IV) Bortezomib: Cost Savings Initiative with Global Economic Impact
  John Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results o...
  John Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• "Guest Speaker" 
  Miami, FL - 1/10/2015
• "Medical Marijuana in Oncology: Benefits and potential pitfalls." 
  6/18/2014
• "Overview of Allogeneic Bone Marrow Transplantation" 
  3/25/2014
• Grand Rounds: "Advanced testing for anemia" 
  Roslindale Community Health Center - 10/31/2013
• Geriatrics Grand Rounds: "Anemia in the Elderly" 
  Boston Medical Center - 10/18/2013
• Grand Rounds: "The Bad Causes of Anemia" 
  Boston Health Care for the Homeless - 6/25/2013
• Internal Medicine Grand Rounds: "Eosinophils in Health and Disease" 
  Boston Medical Center - 1/18/2013
• "Ancillary studies and classification in Hematologic malignancy" 
  4/13/2012
• "Lymphoma 2012: ASH Update" 
  Las Vegas, NV - 4/7/2012
• Internal Medicine Grand Rounds: "Diagnosis of hematologic malignancies for the internist." 
  Sturdy Hospital - 3/7/2012
• Cardiomyopathy Grand Rounds: "IV Iron in Heart Failure" 
  Boston Medical Center - 10/26/2011
• Boston Med Flight Grand Rounds: "Oncologic emergencies" 
  Hanscomb Air Force Base - 10/12/2011
• General Internal Medicine Grand Rounds: "Iron Deficiency" 
  Boston Medical Center - 9/28/2011
• "Leukemia in 2011" 
  Las Vegas, NV - 2/26/2011
• "AL Amyloidosis" 
  3/20/2009
• "MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells" 
  Orlando, FL - 4/2/2001
• Emergency Department Grand Rounds: "Oncologic Emergencies" 
  Boston Medical Center - 4/31/2010
• Join now to see all